![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » MolecuLight’s i:X Bacterial Test Receives FDA’s 510(k) Clearance
MolecuLight’s i:X Bacterial Test Receives FDA’s 510(k) Clearance
![ClearanceStamp_Gray.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Gray.gif?t=1576043982&width=430)
MolecuLight has received the FDA’s 510(k) clearance for its MolecuLight i:X imaging device for detection of wounds containing elevated levels of Pseudomonas aeruginosa.
The Toronto, Canada-based company specializes in point-of-care fluorescence imaging for detection of wounds containing elevated bacterial loads. Its MolecuLight i:X previously received 510(k) clearance from the FDA.
P. aeruginosa is a bacterial pathogen that blocks wound healing and often resists conventional treatment methods. The i:X device works by visualizing fluorescence, enabling point-of-care detection of wounds containing clinically significant levels of the pathogen.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct